Hisamitsu Pharmaceutical Co Inc banner

Intrinsic Value

The intrinsic value of Hisamitsu Pharmaceutical Co Inc (HPX) under the Base Case is 26.06 EUR per share. Compared with the current market price of 31.8 EUR, the stock appears Overvalued by 18% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

HPX Intrinsic Value
€26.06
Overvaluation 18%
Intrinsic Value
Price €31.8
H

HPX is more expensive than usual. It was this expensive or more expensive on just 7% of days in the past 5 years.

Monitor HPX
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €20.85
Get notified when the price drops into your buy zone
Current Price €31.8
Intrinsic Value €26.06
Margin of Safety 20% €20.85
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to HPX

Fundamental Analysis

What Hisamitsu Pharmaceutical Does

Pharmaceuticals Health Care

Hisamitsu Pharmaceutical makes medicines and health products, but it is best known for pain relief patches, creams, and other topical treatments for sore muscles and joints. The company also sells prescription drugs, over-the-counter medicines, and skin-care products, with a strong focus on products that are applied to the body rather than swallowed.

Headquarters
Japan JP
Employees
2 770
IPO date
Sep 1, 1962
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Hisamitsu Pharmaceutical Co Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one HPX stock?

The intrinsic value for Hisamitsu Pharmaceutical Co Inc (HPX) under the Base Case is 26.06 EUR.

Is HPX stock undervalued or overvalued?

Compared with the current market price of 31.8 EUR, the stock appears Overvalued by 18% .

Back to Top